Insider Trading & Ownership of Teresa DeLuca

Location
Nashville, TN
Summary
The estimated net worth of Teresa DeLuca is at least $1,642,089 dollars as of 15 Aug 2025. Teresa DeLuca is the Director of Surgery Partners, Inc. and owns shares of Surgery Partners, Inc. (SGRY) stock worth about $1.03M. Teresa DeLuca is the Director of LifeStance Health Group, Inc. and owns shares of LifeStance Health Group, Inc. (LFST) stock worth about $614.8K. Teresa DeLuca is the Director of 180 Life Sciences Corp. and owns shares of FORUM MARKETS Inc (FRMM) stock worth about $95.
Signature
/s/ Jennifer Baldock, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Teresa DeLuca and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Teresa DeLuca has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,642,089.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Surgery Partners, Inc. ($1,027,234).
  • Past-year value change for that position: -$455,209.

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Teresa DeLuca

SGRY Forms 3/4/5

Surgery Partners, Inc.

Relationship
Director
Holdings value
$1,027,234
Past year net change
-$455,209
Change %
-31%
Report period
11 Aug 2025

Insider Transactions Reported by Teresa DeLuca:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .